4//SEC Filing
Campbell Vyvyan 4
Accession 0001493152-18-002843
CIK 0001354591other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 3:00 PM ET
Size
6.3 KB
Accession
0001493152-18-002843
Insider Transaction Report
Form 4
Campbell Vyvyan
Director10% Owner
Transactions
- Other
Series A Preferred Stock
2017-08-17+1,000,000→ 1,000,000 total - Other
Common Stock
2017-08-17−1,000,000→ 1,000,000 total
Footnotes (1)
- [F1]Conversion of common stock into Series A preferred stock on a 1:1 basis.
Documents
Issuer
PetLife Pharmaceuticals, Inc.
CIK 0001354591
Entity typeother
Related Parties
1- filerCIK 0001700395
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 3:00 PM ET
- Size
- 6.3 KB